Literature DB >> 28688065

Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period.

Tiina Mattila1,2,3, Tuula Vasankari4,5, Harri Rissanen6, Paul Knekt6, Pauli Puukka6, Markku Heliövaara6.   

Abstract

Chronic obstructive pulmonary disease (COPD) has been associated with coronary mortality. Yet, data about the association between COPD and acute myocardial infarction (MI) remain scarce. We aimed to study airway obstruction as a predictor of MI and coronary mortality among 5576 Finnish adults who participated in a national health examination survey between 1978 and 1980. Subjects underwent spirometry, had all necessary data, showed no indications of cardiovascular disease at baseline, and were followed up through record linkage with national registers through 2011. The primary outcome consisted of a major coronary event-that is, hospitalization for MI or coronary death, whichever occurred first. We specified obstruction using the lower limit of normal categorization. Through multivariate analysis adjusted for potential confounding factors for coronary heart disease, hazard ratios (HRs) (with the 95% confidence intervals in parentheses) of a major coronary event, MI, and coronary death reached 1.06 (0.79-1.42), 0.84 (0.54-1.31), and 1.40 (1.04-1.88), respectively, in those with obstruction compared to others. However, in women aged 30-49 obstruction appeared to predict a major coronary event, where the adjusted HR reached 4.21 (1.73-10.28). In conclusion, obstruction appears to predict a major coronary event in younger women only, whereas obstruction closely associates with the risk of coronary death independent of sex and age.

Entities:  

Keywords:  Airway obstruction; Coronary mortality; Epidemiology; Follow-up study; Myocardial infarction

Mesh:

Year:  2017        PMID: 28688065     DOI: 10.1007/s10654-017-0278-3

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  27 in total

1.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Authors:  Claus F Vogelmeier; Gerard J Criner; Fernando J Martinez; Antonio Anzueto; Peter J Barnes; Jean Bourbeau; Bartolome R Celli; Rongchang Chen; Marc Decramer; Leonardo M Fabbri; Peter Frith; David M G Halpin; M Victorina López Varela; Masaharu Nishimura; Nicolas Roche; Roberto Rodriguez-Roisin; Don D Sin; Dave Singh; Robert Stockley; Jørgen Vestbo; Jadwiga A Wedzicha; Alvar Agusti
Journal:  Eur Respir J       Date:  2017-03-06       Impact factor: 16.671

2.  Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study.

Authors:  Luis A García Rodríguez; Mari-Ann Wallander; Elisa Martín-Merino; Saga Johansson
Journal:  Respir Med       Date:  2010-05-18       Impact factor: 3.415

Review 3.  Gender differences in coronary heart disease.

Authors:  Ramzi Y Khamis; Tareq Ammari; Ghada W Mikhail
Journal:  Heart       Date:  2016-04-28       Impact factor: 5.994

Review 4.  A systematic review of early life factors which adversely affect subsequent lung function.

Authors:  A Kouzouna; F J Gilchrist; V Ball; T Kyriacou; J Henderson; A D Pandyan; W Lenney
Journal:  Paediatr Respir Rev       Date:  2016-03-14       Impact factor: 2.726

5.  Association between all-cause and cause-specific mortality and the GOLD stages 1-4: A 30-year follow-up among Finnish adults.

Authors:  Tiina Mattila; Tuula Vasankari; Merja Kanervisto; Tarja Laitinen; Olli Impivaara; Harri Rissanen; Paul Knekt; Pekka Jousilahti; Seppo Saarelainen; Pauli Puukka; Markku Heliövaara
Journal:  Respir Med       Date:  2015-06-09       Impact factor: 3.415

6.  Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort.

Authors:  Joy Miller; Lisa D Edwards; Alvar Agustí; Per Bakke; Peter M A Calverley; Bartolome Celli; Harvey O Coxson; Courtney Crim; David A Lomas; Bruce E Miller; Steve Rennard; Edwin K Silverman; Ruth Tal-Singer; Jørgen Vestbo; Emiel Wouters; Julie C Yates; William Macnee
Journal:  Respir Med       Date:  2013-06-19       Impact factor: 3.415

7.  COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.

Authors:  Stephen Sidney; Michael Sorel; Charles P Quesenberry; Cynthia DeLuise; Stephan Lanes; Mark D Eisner
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

8.  Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

Authors:  Nathaniel M Hawkins; Zhen Huang; Karen S Pieper; Scott D Solomon; Lars Kober; Eric J Velazquez; Karl Swedberg; Marc A Pfeffer; John J V McMurray; Aldo P Maggioni
Journal:  Eur J Heart Fail       Date:  2009-01-27       Impact factor: 15.534

Review 9.  Sex differences in long-term mortality after myocardial infarction: a systematic review.

Authors:  Emily M Bucholz; Neel M Butala; Saif S Rathore; Rachel P Dreyer; Alexandra J Lansky; Harlan M Krumholz
Journal:  Circulation       Date:  2014-07-22       Impact factor: 29.690

10.  Association of heart diseases with COPD and restrictive lung function--results from a population survey.

Authors:  Berne Eriksson; Anne Lindberg; Hana Müllerova; Eva Rönmark; Bo Lundbäck
Journal:  Respir Med       Date:  2012-11-03       Impact factor: 3.415

View more
  3 in total

1.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

2.  Risk of Coronary Heart Disease in People with Chronic Obstructive Pulmonary Disease: A Meta-Analysis.

Authors:  Jia-Jie Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-10-27

3.  Low lung function and the risk of incident chronic kidney disease in the Malmö Preventive Project cohort.

Authors:  Suneela Zaigham; Anders Christensson; Per Wollmer; Gunnar Engström
Journal:  BMC Nephrol       Date:  2020-04-08       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.